Coronavirus disease-2019 and heart: assessment of troponin and cardiovascular comorbidities as prognostic markers in patients hospitalized with coronavirus disease-2019 in a tertiary center in Brazil
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | PINESI, Henrique Trombini | |
dc.contributor.author | GIUGNI, Fernando Rabioglio | |
dc.contributor.author | MATUCK, Bruna Romanelli Scarpa | |
dc.contributor.author | PITTA, Fabio Grusnpun | |
dc.contributor.author | GARZILLO, Cibele Larrosa | |
dc.contributor.author | LIMA, Eduardo Gomes | |
dc.contributor.author | KALIL FILHO, Roberto | |
dc.contributor.author | SERRANO JUNIOR, Carlos Vicente | |
dc.contributor.groupauthor | HCFMUSP COVID 19 Study Grp | |
dc.date.accessioned | 2023-10-30T14:25:28Z | |
dc.date.available | 2023-10-30T14:25:28Z | |
dc.date.issued | 2023 | |
dc.description.abstract | OBJECTIVE: Our study aimed to evaluate the correlation of cardiac troponin T levels with comorbidities and in-hospital outcomes in patients with coronavirus disease-2019 in Brazil.METHODS: Data from a cohort of 3,596 patients who were admitted with suspected coronavirus disease-2019 in a Brazilian tertiary center, between March and August 2020, were reviewed. A total of 2,441 (68%) patients had cardiac troponin T determined in the first 72 h of admission and were stratified into two groups: elevated cardiac troponin T (cardiac troponin T >0.014 ng/mL) and normal cardiac troponin T. Associations between troponin, comorbidities, biomarkers, and outcomes were assessed. Regression models were built to assess the association of several variables with in-hospital mortality.RESULTS: A total of 2,441 patients were embraced, of which 924 (38%) had normal cardiac troponin T and 1,517 (62%) had elevated cardiac troponin T. Patients with elevated cardiac troponin T were older and had more comorbidities, such as cardiovascular disease, hypertension, diabetes, arrhythmia, renal dysfunction, liver disease, stroke, cancer, and dementia. Patients with abnormal cardiac troponin T also had more altered laboratory parameters on admission (i.e., leukocytes, C-reactive protein, D-dimer, and B-type natriuretic peptide), as well as more need for intensive care unit, vasoactive drugs, mechanical ventilation, dialysis, and blood transfusion. All-cause mortality was markedly higher among patients with increased cardiac troponin T (42 vs. 16%, P<0.001). Multiple regression analysis demonstrated that in-hospital mortality was not independently associated with troponin elevation.CONCLUSION: This study showed that cardiac troponin T elevation at admission was common and associated with several comorbidities, biomarkers, and clinical outcomes in patients hospitalized with coronavirus disease-2019, but it was not an independent marker of in-hospital mortality. | eng |
dc.description.index | MEDLINE | |
dc.description.index | PubMed | |
dc.description.index | WoS | |
dc.description.index | Scopus | |
dc.identifier.citation | REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.69, n.7, article ID e20230350, 8p, 2023 | |
dc.identifier.doi | 10.1590/1806-9282.20230350 | |
dc.identifier.eissn | 1806-9282 | |
dc.identifier.issn | 0104-4230 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/56019 | |
dc.language.iso | eng | |
dc.publisher | ASSOC MEDICA BRASILEIRA | eng |
dc.relation.ispartof | Revista da Associacao Medica Brasileira | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright ASSOC MEDICA BRASILEIRA | eng |
dc.subject | COVID-19 | eng |
dc.subject | Troponin | eng |
dc.subject | Cardiovascular disease | eng |
dc.subject | Myocardial ischemia | eng |
dc.subject.other | myocardial injury | eng |
dc.subject.wos | Medicine, General & Internal | eng |
dc.title | Coronavirus disease-2019 and heart: assessment of troponin and cardiovascular comorbidities as prognostic markers in patients hospitalized with coronavirus disease-2019 in a tertiary center in Brazil | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 0 | |
hcfmusp.contributor.author-fmusphc | HENRIQUE TROMBINI PINESI | |
hcfmusp.contributor.author-fmusphc | FERNANDO RABIOGLIO GIUGNI | |
hcfmusp.contributor.author-fmusphc | BRUNA ROMANELLI SCARPA | |
hcfmusp.contributor.author-fmusphc | FABIO GRUNSPUN PITTA | |
hcfmusp.contributor.author-fmusphc | CIBELE LARROSA GARZILLO | |
hcfmusp.contributor.author-fmusphc | EDUARDO GOMES LIMA | |
hcfmusp.contributor.author-fmusphc | ROBERTO KALIL FILHO | |
hcfmusp.contributor.author-fmusphc | CARLOS VICENTE SERRANO JUNIOR | |
hcfmusp.description.articlenumber | e20230350 | |
hcfmusp.description.issue | 7 | |
hcfmusp.description.volume | 69 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 37466607 | |
hcfmusp.origem.scielo | SCIELO:S0104-42302023000700619 | |
hcfmusp.origem.scopus | 2-s2.0-85165518952 | |
hcfmusp.origem.wos | WOS:001033719400022 | |
hcfmusp.publisher.city | SAO PAULO | eng |
hcfmusp.publisher.country | BRAZIL | eng |
hcfmusp.relation.reference | [Anonymous], COR BRAS | eng |
hcfmusp.relation.reference | Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516 | eng |
hcfmusp.relation.reference | Changal K, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-02450-3 | eng |
hcfmusp.relation.reference | Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045 | eng |
hcfmusp.relation.reference | Cunningham JW, 2021, CIRCULATION, V144, P177, DOI 10.1161/CIRCULATIONAHA.121.054969 | eng |
hcfmusp.relation.reference | Guimaraes PO, 2021, IJC HEART VASC, V36, DOI 10.1016/j.ijcha.2021.100853 | eng |
hcfmusp.relation.reference | Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017 | eng |
hcfmusp.relation.reference | Han H, 2020, J MED VIROL, V92, P819, DOI 10.1002/jmv.25809 | eng |
hcfmusp.relation.reference | Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X | eng |
hcfmusp.relation.reference | Imazio M, 2020, HEART, V106, P1127, DOI 10.1136/heartjnl-2020-317186 | eng |
hcfmusp.relation.reference | Iorio A, 2022, AM J CARDIOL, V167, P125, DOI 10.1016/j.amjcard.2021.11.054 | eng |
hcfmusp.relation.reference | Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1016/j.jacc.2020.06.007, 10.1101/2020.04.20.20072702] | eng |
hcfmusp.relation.reference | Marcilio I, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2166 | eng |
hcfmusp.relation.reference | Metkus TS, 2021, CIRCULATION, V143, P553, DOI 10.1161/CIRCULATIONAHA.120.050543 | eng |
hcfmusp.relation.reference | Nasir Kansestani Atefeh, 2021, J Tehran Heart Cent, V16, P1, DOI 10.18502/jthc.v16i1.6594 | eng |
hcfmusp.relation.reference | Omland T, 2020, CIRCULATION, V142, P1878, DOI 10.1161/CIRCULATIONAHA.120.050089 | eng |
hcfmusp.relation.reference | Polcwiartek Christoffer, 2022, Am Heart J Plus, V14, P100131, DOI 10.1016/j.ahjo.2022.100131 | eng |
hcfmusp.relation.reference | Sandoval Y, 2020, J AM COLL CARDIOL, V76, P1244, DOI 10.1016/j.jacc.2020.06.068 | eng |
hcfmusp.relation.reference | Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950 | eng |
hcfmusp.relation.reference | Torres-Torres J, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14020271 | eng |
hcfmusp.relation.reference | von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120 | eng |
hcfmusp.relation.reference | Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3 | eng |
hcfmusp.scopus.lastupdate | 2024-04-12 | |
relation.isAuthorOfPublication | bd5b74ea-0f97-4a4f-8d10-c5038caf1eac | |
relation.isAuthorOfPublication | 6bc84a15-5eb1-45a7-938e-f982121c1db0 | |
relation.isAuthorOfPublication | 429df4f2-8550-4660-a2c4-033e817d5be9 | |
relation.isAuthorOfPublication | 35ce8a2e-9a92-4f00-b08b-432dcb07303e | |
relation.isAuthorOfPublication | fa91ff34-659d-496b-8026-4b56f389967e | |
relation.isAuthorOfPublication | a354095f-ee4d-48b4-8684-c6cdfa32b731 | |
relation.isAuthorOfPublication | c934e4bf-7bb3-4e4d-aaac-07d8be41a3ac | |
relation.isAuthorOfPublication | 2c371782-3a13-4c0b-8caf-b4ad0359b67b | |
relation.isAuthorOfPublication.latestForDiscovery | bd5b74ea-0f97-4a4f-8d10-c5038caf1eac |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_PINESI_Coronavirus_disease2019_and_heart_assessment_of_troponin_and_2023.PDF
- Tamanho:
- 370.24 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - ODS/03